SCHEMBL7991723

SCHEMBL7991723

CCCc1nc2ncn(Cc3cccc(Cl)c3)c2c(=O)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.49
GLA P06280 1/20 0.49
HTT P42858 1/20 0.49
UBE2N P61088 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HPGD P15428 1/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 1/20 0.46
HCAR2 Q8TDS4 1/20 0.42
YTHDC1 Q96MU7 2/20 0.42
BRD4 O60885 2/20 0.40
BRD2 P25440 1/20 0.40
BRD3 Q15059 1/20 0.40
BRDT Q58F21 1/20 0.40
ACP1 P24666 1/20 0.40
MAPK1 P28482 1/20 0.40
GAA P10253 1/20 0.40
HTR6 P50406 1/20 0.39
TRPA1 O75762 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984753 0.91 SMN1; SMN2 (0.51) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7988672 0.89 SMN1; SMN2 (0.47) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7989405 0.89 SMN1; SMN2 (0.57) SMN1; SMN2HPGDALDH1A1KMT2AHCAR2
SCHEMBL7988657 0.88 HPGD (0.45) SMN1; SMN2HTTHPGDALDH1A1KMT2A
SCHEMBL7988482 0.87 PDE1A (0.46) SMN1; SMN2HPGDALDH1A1KMT2AHCAR2
SCHEMBL7987671 0.86 SMN1; SMN2 (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7984130 0.85 GAA (0.52) SMN1; SMN2HPGDALDH1A1KMT2AHCAR2
Hydrochloric Acid SCHEMBL7987800 0.85 HPGD (0.48) SMN1; SMN2GLAHTTUBE2NL3MBTL1
SCHEMBL7989373 0.83 HPGD (0.46) SMN1; SMN2HTTHPGDALDH1A1KMT2A
SCHEMBL7974253 0.83 HPGD (0.46) SMN1; SMN2L3MBTL1HPGDALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed